C4 Therapeutics CCCC
NASDAQ CCCC
$3.13 +0.02 (+0.48%)
At close: Sep 29, 2026 · 4:00 PM EDT

C4 Therapeutics (CCCC) Common Equity (2019 - 2026)

Updated

C4 Therapeutics' Common Equity came in at $247.27 million for Q2 2026, up 42.1% from $174.06 million a year earlier and up 5.6% from the prior quarter.

Analysis

C4 Therapeutics (CCCC) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, C4 Therapeutics' Common Equity was $256.59 million, up 18.8% from FY2024.

  • Common Equity carries a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
  • Going back by year, Common Equity was $215.99 million in FY2024 (-12.2%), $246.11 million in FY2023 (-14.9%), $289.23 million in FY2022 (-25.8%) and $389.61 million in FY2021 (+38.8%).
  • The five-year range for quarterly Common Equity is $154.41 million (Q3 2025) to $398.78 million (Q3 2021).
  • Year-over-year, Common Equity has increased for three consecutive quarters, with an average decline of 1.2% over the last eight quarters.
  • The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 42.1%), and the weakest in Q3 2025 (a decline of 36.4%).
  • Business Quant data shows CCCC's Common Equity at $234.25 million (Q1 2026), $256.59 million (Q4 2025) and $154.41 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 C4 Therapeutics 383.47 Mn -546.29 Mn - 247.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 247.27 Mn
Mar 31, 2026 234.25 Mn
Dec 31, 2025 256.59 Mn
Sep 30, 2025 154.41 Mn
Jun 30, 2025 174.06 Mn
Mar 31, 2025 195.14 Mn
Dec 31, 2024 215.99 Mn
Sep 30, 2024 242.66 Mn
Jun 30, 2024 247.06 Mn
Mar 31, 2024 258.28 Mn
Dec 31, 2023 246.11 Mn
Sep 30, 2023 216.02 Mn
Jun 30, 2023 233.71 Mn
Mar 31, 2023 262.47 Mn
Dec 31, 2022 289.23 Mn
Sep 30, 2022 318.18 Mn
Jun 30, 2022 344.59 Mn
Mar 31, 2022 364.53 Mn
Dec 31, 2021 389.61 Mn
Sep 30, 2021 398.78 Mn
API Access

C4 Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=CCCC&period=max&api_key=YOUR_API_KEY